Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations

Curr Med Res Opin. 2017 Apr;33(4):781-782. doi: 10.1080/03007995.2017.1284049. Epub 2017 Feb 3.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Mutation*
  • Neoplasms
  • Repressor Proteins / genetics
  • Transcription Factors / genetics*

Substances

  • ASXL1 protein, human
  • ASXL2 protein, human
  • ASXL3 protein, human
  • Repressor Proteins
  • Transcription Factors